View the REPOTREMAKS registration information details.
Back to drug list
ItemsDrug Registration information
ID999
No999
Brand NameREPOTREMAKS
IngredientsREPOTRECTINIB 40 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 60'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsLOCALLY ADVANCED OR METASTATIC ROS1-POSITIVE NON SMALL CELL LUNG CANCER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE CAPSULE CONTAINS WHITE POWDER
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY NO. 2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 L 1145/24
FDD Registration Date12/07/2024
Expiry Date11/07/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA